Suspension of trading
Sector Canntab Therapeutics Limited Deutsche Boerse AG
Stocks
TBF1
CA1377991023
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000500 EUR | -.--% |
|
-.--% | - |
| 24-04-14 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.70% | -2.79% | +4.12% | -3.40% | -10.45% | -9.05% | -6.89% | -26.64% | +2.79% | 13.54B | |
| -0.81% | -3.21% | +14.60% | -0.07% | +9.25% | +4.93% | +2.37% | +71.09% | -7.84% | 5.11B | |
| -0.99% | -4.67% | +5.11% | -10.21% | -22.85% | -31.60% | -56.22% | -29.45% | -18.39% | 5.11B | |
| -0.12% | +0.90% | +8.77% | -2.65% | -1.17% | +5.57% | -29.80% | -12.73% | +44.98% | 4.18B | |
| -1.13% | -2.80% | -0.70% | -12.90% | -19.36% | -7.89% | -5.93% | +28.95% | +111.44% | 3.69B | |
| -0.93% | -4.47% | +7.05% | -10.38% | -2.47% | -3.06% | +3.55% | +64.32% | -12.96% | 3.54B | |
| -0.64% | -2.33% | +10.30% | +3.88% | +3.05% | -3.66% | +15.21% | +20.95% | -45.44% | 3.46B | |
| -0.44% | -1.00% | +2.00% | -1.74% | +1.02% | -12.80% | -15.78% | -19.39% | - | 2.48B | |
| +0.71% | -2.34% | +3.82% | +2.45% | +8.88% | -2.38% | +44.27% | +105.00% | +104.07% | 1.87B | |
| -0.72% | -1.90% | +3.19% | -10.13% | -12.60% | -28.93% | -12.41% | -26.09% | -25.52% | 1.75B | |
| -0.46% | -1.37% | +4.85% | -2.04% | -3.14% | -5.88% | -18.95% | -0.69% | -35.33% | 1.63B | |
| +2.35% | +2.05% | +10.09% | +1.75% | -0.85% | -16.11% | -31.43% | -25.74% | -41.96% | 1.52B | |
| +1.81% | +1.46% | +8.62% | -3.94% | -9.53% | -22.69% | +44.61% | +85.77% | +60.66% | 1.48B | |
| -1.47% | +1.96% | +14.71% | -3.31% | +7.22% | -19.45% | -17.31% | -0.32% | -60.87% | 1.19B | |
| -0.89% | -0.30% | +1.83% | -7.80% | -5.25% | -13.30% | -14.30% | +2.69% | -33.37% | 1.17B | |
| +0.52% | -0.66% | +8.30% | -0.07% | -8.12% | -15.82% | -39.34% | -11.42% | -31.41% | 1.17B | |
| +0.72% | +7.11% | +7.65% | +12.53% | +17.22% | +15.62% | +79.57% | -51.10% | +797.87% | 1.11B | |
| -1.34% | -4.95% | -1.41% | -15.18% | -21.97% | -33.41% | -55.76% | -65.43% | -33.39% | 1.03B | |
| -0.22% | -0.22% | +1.55% | -7.85% | +5.29% | -25.29% | -43.46% | -33.62% | -80.44% | 929M | |
| Average | -0.25% | +0.70% | +6.02% | -3.74% | -3.46% | -11.85% | -8.32% | +4.01% | +38.60% | 2.95B | |
| Weighted average by Cap. | -0.49% | +0.13% | +6.12% | -4.05% | -5.62% | -9.66% | -9.54% | +4.09% | +19.53% |
- Stock Market
- Stocks
- CTABF Stock
- TBF1 Stock
- Sector Canntab Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
